scientific Sessions

Novel Cancer Vaccines

Innovative cancer vaccines are revolutionizing immunotherapy by harnessing the immune system to target tumors. These vaccines, including peptide-based, DNA, and mRNA platforms, are designed to stimulate immune responses against cancer-specific antigens. Advances in personalized neoantigen vaccines offer tailored approaches for individual patients, improving efficacy. At the Cancer Research and Development Conference 2025, we will discuss how these novel cancer vaccines promise to prevent cancer recurrence, enhance existing therapies, and provide a proactive defence against malignancies.

Related Sessions

Advances in Nanotechnology for Cancer Treatment
Cellular Therapies Beyond CAR-T
The Role of Epigenetics in Cancer Diagnosis
Cancer Genomics and Epigenomics
Liquid Biopsy Innovations
Immunomodulatory Molecules in Cancer Therapy
Pediatric Oncology
Advances in Cancer Genetics and Genomics
Novel Cancer Vaccines
Systems Biology in Cancer Research
Cutting-Edge Therapies in Cancer Treatment
Tumour Suppressor Molecules in Cancer Therapy
Molecular Imaging Agents for Cancer
Organoids and 3D Bioprinting in Cancer R&D
Don't miss our future updates!

Get in Touch